Literature DB >> 31079510

LEARN2MOVE 0-2 years, a randomized early intervention trial for infants at very high risk of cerebral palsy: neuromotor, cognitive, and behavioral outcome.

Tjitske Hielkema1,2, Elisa G Hamer1,3, Anke G Boxum1, Sacha La Bastide-Van Gemert4, Tineke Dirks1, Heleen A Reinders-Messelink2,5, Carel G B Maathuis2, Johannes Verheijden6, Jan H B Geertzen2, Mijna Hadders-Algra1.   

Abstract

Purpose: Evidence for efficacy of early intervention in infants at high risk of cerebral palsy (CP) is limited. We compared outcome of infants at very high risk of CP after receiving the family centered program COPing with and CAring for infants with special needs (COPCA) or typical infant physiotherapy.Materials and methods: Forty-three infants were randomly assigned before the corrected age of 9 months to 1 year of COPCA (n = 23) or typical infant physiotherapy (n = 20). Neuromotor development, cognition, and behavior was assessed until 21 months corrected age. Video-recorded physiotherapy sessions were quantitatively analyzed for further process analyses. Outcome was evaluated with nonparametric tests and linear mixed effect models.
Results: During and after the interventions, infant outcome in both intervention groups was similar [primary outcome Infant Motor Profile: COPCA 82 (69-94), typical infant physiotherapy 81 (69-89); Hodges Lehman estimate of the difference 0 (confidence interval -5;4)]. Outcome was not associated with contents of intervention.Conclusions: One year of COPCA and 1 year of typical infant physiotherapy in infants at high risk of CP resulted in similar neurodevelopmental outcomes. It is conceivable that combinations of active ingredients from different approaches are needed for effective early intervention.IMPLICATIONS FOR REHABILITATIONFor infants at very high risk of cerebral palsy, 1 year of intervention with the family-centred programme Coping with and Caring for infants with special needs resulted in similar infant outcome as 1 year of typical infant physiotherapy.Infant's neuromotor, cognitive, and behavioural outcome was not associated with specific interventional elements, implying that the various elements may have a similar effect on developmental outcome.We suggest that a specific mix of ingredients of different approaches may work best, resulting in comprehensive care including both infant and family needs.

Entities:  

Keywords:  Cerebral palsy; behavior; cognition; early intervention; infancy; neurodevelopment

Mesh:

Year:  2019        PMID: 31079510     DOI: 10.1080/09638288.2019.1610508

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  5 in total

1.  Effect of Motor Intervention for Infants and Toddlers With Cerebral Palsy: A Systematic Review and Meta-analysis.

Authors:  Aubrey Baker; Natalie Niles; Lynn Kysh; Barbara Sargent
Journal:  Pediatr Phys Ther       Date:  2022-06-07       Impact factor: 1.452

Review 2.  Early intervention evidence for infants with or at risk for cerebral palsy: an overview of systematic reviews.

Authors:  Diane L Damiano; Egmar Longo
Journal:  Dev Med Child Neurol       Date:  2021-04-06       Impact factor: 4.864

3.  The Significance of Touch in Pediatric Physiotherapy.

Authors:  Marit Sørvoll; Gunn Kristin Øberg; Gay L Girolami
Journal:  Front Rehabil Sci       Date:  2022-05-31

4.  The Effectiveness of Sensory Integration Interventions on Motor and Sensory Functions in Infants with Cortical Vision Impairment and Cerebral Palsy: A Single Blind Randomized Controlled Trial.

Authors:  Mustafa Cemali; Serkan Pekçetin; Esra Akı
Journal:  Children (Basel)       Date:  2022-07-27

5.  Tele-care intervention performed by parents involving specific task- environment- participation (STEP protocol) for infants at risk for developmental delay: protocol of randomized controlled clinical trial.

Authors:  Camila Resende Gâmbaro Lima; Adriana Neves Dos Santos; Mariana Martins Dos Santos; Catherine Morgan; Nelci Adriana Cicuto Ferreira Rocha
Journal:  BMC Pediatr       Date:  2022-01-20       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.